Mettler-Toledo International (NYSE:MTD) Now Covered by The Goldman Sachs Group

The Goldman Sachs Group began coverage on shares of Mettler-Toledo International (NYSE:MTD) in a research report report published on Tuesday, Marketbeat reports. The brokerage issued a neutral rating and a $1,475.00 price objective on the medical instruments supplier’s stock.

Several other research analysts have also commented on MTD. Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 7th. Morgan Stanley began coverage on shares of Mettler-Toledo International in a research report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 target price on the stock. Barclays raised their target price on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a report on Monday, November 10th. Citigroup upped their price target on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. Finally, Bank of America increased their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Five research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,424.17.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,371.94 on Tuesday. The business’s 50-day moving average is $1,395.79 and its 200-day moving average is $1,288.40. The company has a market capitalization of $28.03 billion, a price-to-earnings ratio of 34.21, a P/E/G ratio of 4.46 and a beta of 1.40. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same period last year, the company posted $10.21 earnings per share. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Equities research analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Gerry Keller sold 236 shares of the stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the completion of the sale, the insider directly owned 159 shares of the company’s stock, valued at approximately $225,554.22. This represents a 59.75% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shawn Vadala sold 1,895 shares of the firm’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the sale, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,696,789.76. The trade was a 26.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 19,565 shares of company stock valued at $28,683,737 over the last 90 days. Corporate insiders own 0.77% of the company’s stock.

Institutional Trading of Mettler-Toledo International

Several hedge funds and other institutional investors have recently modified their holdings of the company. Versant Capital Management Inc boosted its position in shares of Mettler-Toledo International by 42.1% during the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 8 shares during the period. SJS Investment Consulting Inc. grew its stake in shares of Mettler-Toledo International by 2,700.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 27 shares in the last quarter. WPG Advisers LLC acquired a new stake in shares of Mettler-Toledo International in the first quarter valued at approximately $41,000. NewSquare Capital LLC lifted its position in shares of Mettler-Toledo International by 94.4% in the second quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 17 shares in the last quarter. Finally, MV Capital Management Inc. boosted its holdings in Mettler-Toledo International by 50.0% during the second quarter. MV Capital Management Inc. now owns 36 shares of the medical instruments supplier’s stock worth $42,000 after purchasing an additional 12 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.